IL-22 can promote the proliferation of HSCs in vitro and accelerate the progression of liver fibrosis from hepatitis C virus recurrence after orthotopic liver transplantation (HCV-OLT) (62). This evidence concerns the gene IL22 and Hepatic fibrosis.